Emerging roles of IL-9 and Th9 cells in respiratory viral illnesses
Seminars in Immunology · 2026-03 · 81 · 102017
DOI: 10.1016/j.smim.2026.102017 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Immunology, 2026-03. Verfasst von Jyotsna Dandotiya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Immuno-biology and Immunotherapy, Translational Health Science and Technology Institute, Faridabad, 121 001, India. Hauptthemen laut MEDLINE: Interleukin-9, T-Lymphocytes, Helper-Inducer, COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Translational Health Science and Technology Institute, Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Upon antigenic stimulation and cytokine cues, CD4⁺ T cells differentiate into specialized helper subsets, giving rise to Th1, Th2, Th9 and Th17 cell lineages. These subsets orchestrate distinct immune functions that protect the host but can also drive immunopathology when dysregulated. The classical Th1-Th2 paradigm expanded with the discovery of Th17 and Th9 cells, revealing greater diversity and complexity in Th cell biology. Th9 cells, generated under the influence of TGF-β and IL-4, are defined by robust production of interleukin-9 (IL-9). IL-9 is now recognized as a multifunctional mediator produced by Th9 cells, mast cells, ILC2s, Tregs and certain Th17 subsets. Fate-mapping and reporter mouse models have improved our understanding of IL-9-producing immunocytes, though limitations remain in defining temporal and tissue-specific dynamics. As shown earlier, IL-9 promotes mastcell proliferation, mucus hypersecretion, epithelial changes and airway remodelling in allergic inflammation and asthma. Genetic studies have linked IL-9/IL-9 receptor variants to increased susceptibility to allergic diseases such as asthma. Similarly, during respiratory viral infections, including RSV and COVID-19, IL-9 amplifies type 2 inflammation, granulocyte recruitment and mucus production, exacerbating airway obstruction. In fact, emerging evidence implicates a Foxo1-IL-9 axis in COVID-19, where IL-9 enhances lung inflammation and impairs antiviral interferon-stimulated gene responses. Collectively, IL-9 represents a context-dependent driver of virus-induced lung pathology and a promising therapeutic target requiring deeper mechanistic and translational investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Immuno-biology and Immunotherapy, Translational Health Science and Technology Institute, Faridabad, 121 001, India.
- Artemis Education and Research Foundation, Artemis Hospital, Gurugram, 122 001, India.
- Centre for Immuno-biology and Immunotherapy, Translational Health Science and Technology Institute, Faridabad, 121 001, India. Electronic address: aawasthi@thsti.res.in.
Förderung
- Translational Health Science and Technology Institute
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
Dandotiya, J., Sadhu, S., Chandwaskar, R. R., & Awasthi, A. (2026). Emerging roles of IL-9 and Th9 cells in respiratory viral illnesses. Seminars in Immunology, 81, 102017. https://doi.org/10.1016/j.smim.2026.102017
Vancouver
Dandotiya J, Sadhu S, Chandwaskar RR, Awasthi A. Emerging roles of IL-9 and Th9 cells in respiratory viral illnesses. Seminars in Immunology. 2026;81:102017. doi:10.1016/j.smim.2026.102017
BibTeX
@article{Dandotiya2026,
author = {Dandotiya, Jyotsna and Sadhu, Srikanth and Chandwaskar, Rucha R and Awasthi, Amit},
title = {Emerging roles of IL-9 and Th9 cells in respiratory viral illnesses},
journal = {Seminars in Immunology},
year = {2026},
volume = {81},
pages = {102017},
doi = {10.1016/j.smim.2026.102017}
}
EUVIMED